Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Munoz, AJ; Souto, JC; Lecumberri, R; Obispo, B; Sanchez, A; Aparicio, J; Aguayo, C; Gutierrez, D; Palomo, AG; Fanjul, V; del Rio-Bermudez, C; Vinuela-Beneitez, MC; Hernandez-Presa, MA.

Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning

THROMBOSIS RESEARCH. 2023; 228: 181-188 Nº de citas: 23 [doi:10.1016/j.thromres.2023.06.015]

Johnston, S; Emde, A; Barrios, C; Srock, S; Neven, P; Martin, M; Cameron, D; Janni, W; Gnant, M.

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences

Jnci Cancer Spectrum. 2023; 7(4): Nº de citas: 9 [doi:10.1093/jncics/pkad045]

Dasari, A; Lonardi, S; Garcia-Carbonero, R; Elez, E; Yoshino, T; Sobrero, A; Yao, JM; Garcia-Alfonso, P; Kocsis, J; Gracian, AC; Sartore-Bianchi, A; Satoh, T; Randrian, V; Tomasek, J; Chong, GF; Paulson, AS; Masuishi, T; Jones, J; Csoszi, T; Cremolini, C; Ghiringhelli, F; Shergill, A; Hochster, HS; Krauss, J; Bassam, A; Ducreux, M; Elme, A; Faugeras, L; Kasper, S; Van Cutsem, E; Arnold, D; Nanda, S; Yang, Z; Schelman, WR; Kania, M; Tabernero, J; Eng, C.

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

LANCET. 2023; 402(10395): 41-53 Nº de citas: 170 [doi:10.1016/S0140-6736(23)00772-9]

Valcarcel, S; Gallego, J; Jimenez-Fonseca, P; Diez, M; de Castro, EM; Hernandez, R; Arrazubi, V; Custodio, A; Cano, JM; Montes, AF; Macias, I; Visa, L; Calvo, A; Tocino, RV; Lago, NM; Limon, ML; Granja, M; Gil, M; Pimentel, P; Macia-Rivas, L; Perez, CH; Mangas, M; Carnicero, AM; Cerda, P; Gonzalez, LG; Navalon, FG; Rambla, MDM; Richard, MM; Carmona-Bayonas, A.

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7): 4077-4089 Nº de citas: 2 [doi:10.1007/s00432-022-04294-6]

Escudero-Vilaplana, V; Collado-Borrell, R; Martinez-Sagrera, PG; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Hoyo-Munoz, A; Gilarranz, YJ; Marzal-Alfaro, B; Herranz, A; Martin, M; Sanjurjo, M.

Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; 149(7): 2855-2882 Nº de citas: 4 [doi:10.1007/s00432-022-04172-1]

Martin, M; Carrasco, E; Rodriguez-Lescure, A; Andres, R; Servitja, S; Anton, A; Ruiz-Borrego, M; Bermejo, B; Guerrero, A; Ramos, M; Santaballa, A; Munoz, M; Cruz, J; Lopez-Tarruella, S; Chacon, JI; Alvarez, I; Martinez, P; Miralles, JJ; Polonio, O; Jara, C; Aguiar-Bujanda, D.

Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El alamo IV registry

BREAST CANCER RESEARCH AND TREATMENT. 2023; 201(2): 151-159 Nº de citas: 6 [doi:10.1007/s10549-023-07002-1]

Canovas, MS; Garay, DF; Martinez, FG; Vazquez, EB; de Mena, ML; Adrian, SG; Pacheco-Barcia, V; Lavin, DC; de Castro, EM; de Soignie, AMMF; Martinez, E; Blanco, ABR; Escobar, IG; Coloma, CS; Boluda, NB; Garcia, MEG; Arroniz, MG; Martin, AJM.

Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group

CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; 26(1): 171-177 [doi:10.1007/s12094-023-03233-2]

Escobar, Y; Ramchandani, A; Salgado, M; Castillo-Trujillo, A; de Castro, EM; de Corcuera, ID; Vera, R; Lacalle, A; Torres, I; Segura, PP; Hierro, C; de Prado, DS; Cotes, A; Zafra, GM; Fabregat, RM; Virizuela, J; Villa, JC; Borrega, P; Jimenez-Fonseca, P.

What do patients and oncologists think about the evaluation and management of cancer-related anorexia-cachexia? The Quasar_SEOM study

CLINICAL & TRANSLATIONAL ONCOLOGY. 2023; 25(12): 3479-3491 Nº de citas: 1 [doi:10.1007/s12094-023-03212-7]

Muñoz A; Ay C; Grilz E; López S; Font C; Pachón V; Castellón V; Martínez-Marín V; Salgado M; Martínez E; Calzas J; Ortega L; Rupérez A; Salas E; Pabinger I; Soria JM.

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts.

JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(16): 2911-2925 Nº de citas: 40 [doi:10.1200/JCO.22.00255]

Verso, M; Munoz, A; Agnelli, G.

Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents

SEMINARS IN ONCOLOGY. 2023; 50(3-5): 67-70 Nº de citas: 2 [doi:10.1053/j.seminoncol.2023.05.002]

Alvarez, RA; Manzano, A; Pujol, CA; Raventos, VA; Correa, R; Jurado, JC; Fernandez, JA; del Muro, XG; Gonzalez, JA; Hindi, N; Lominchar, PL; Martinez-Trufero, J; Mendez, R; Munoz, M; Casares, CM; Castellanos, FO; Fernandez, RO; Gonzalez, MP; Redondo, A; Morales, CV; Asencio, JM.

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS)

Cancers. 2023; 15(12): Nº de citas: 9 [doi:10.3390/cancers15123194]

Jimenez-Fonseca, P; Sastre, J; Garcia-Alfonso, P; Gomez-Espana, MA; Salud, A; Gil, S; Rivera, F; Reina, JJ; Quintero, G; Valladares-Ayerbes, M; Safont, MJ; La Casta, A; Robles-Diaz, L; Garcia-Paredes, B; Lopez, RL; Guillot, M; Gallego, J; Alonso-Orduna, V; Diaz-Rubio, E; Aranda, E.

Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNu-1 and Phase II VISNu-2 Randomized Trials

CLINICAL COLORECTAL CANCER. 2023; 22(2): 222-230 Nº de citas: 3 [doi:10.1016/j.clcc.2023.02.004]

Arranz-Herrero, J; Presa, J; Rius-Rocabert, S; Utrero-Rico, A; Arranz-Arija, JA; Lalueza, A; Escribese, MM; Ochando, J; Soriano, V; Nistal-Villan, E.

Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2023; 131: 173-179 Nº de citas: 5 [doi:10.1016/j.ijid.2023.04.003]

Castellanos-Montealegre, M; Rivera-Theruel, F; Garcia-Coll, V; Rioja-Collado, N; Gil-Herrero, L; Lopez-Tarruella, S; Sanz, MM; Gonzalez, SC; Aramburo, AF; Ruiz-Casado, A; Laundos, R; Casla-Barrio, S.

Impact of the COVID-19 Lockdown on Physical Activity Levels and Health Parameters in Young Adults with Cancer

Current Oncology. 2023; 30(6): 5395-5408 Nº de citas: 1 [doi:10.3390/curroncol30060409]

Garcia-Pardo, M; Aparicio, I; Martinez, I; Arregui, M; Tirado, V; Galera, M; Alvarez, R; Calles, A.

Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue Testing

CLINICAL LUNG CANCER. 2023; 24(4): 366-370 Nº de citas: 3 [doi:10.1016/j.cllc.2023.02.003]

Vedovati, MC; Giustozzi, M; Munoz, A; Bertoletti, L; Cohen, AT; Klok, FA; Connors, JM; Bauersachs, R; Brenner, B; Campanini, M; Becattini, C; Agnelli, G.

Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism

EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2023; 112: 29-36 Nº de citas: 33 [doi:10.1016/j.ejim.2023.02.003]

Bueno-Muino, C; Echavarria, I; Lopez-Tarruella, S; Roche-Molina, M; del Monte-Millan, M; Massarrah, T; Jerez, Y; de la Pena, FA; Garcia-Saenz, JA; Moreno, F; Rodriguez-Lescure, A; Malon-Gimenez, D; Garcia, AIB; Marin-Aguilera, M; Galvan, P; Braso-Maristany, F; Waks, AG; Tolaney, SM; Mittendorf, EA; Vivancos, A; Villagrasa, P; Parker, JS; Perou, CM; Pare, L; Villacampa, G; Prat, A; Martin, M.

Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab

JAMA Oncology. 2023; 9(6): 841-846 Nº de citas: 21 [doi:10.1001/jamaoncol.2023.0187]

Ruiz-Briones, P; Escudero-Vilaplana, V; Collado-Borrell, R; Vicente-Valor, J; Alvarez, R; Villanueva-Bueno, C; Narrillos-Moraza, A; Herranz, A; Sanjurjo, M.

Possible heart failure caused by osimertinib in a lung cancer patient

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023; 29(4): 1015-1020 Nº de citas: 4 [doi:10.1177/10781552221143787]